10-K: PMV Consumer stays a shell, eyes deal hunt

PMV Consumer Acquisition Corp. filed its 2025 10-K showing no revenues, a small net loss, OTC Pink trading, tight cash burn, and continued pursuit of a business opportunity, primarily in consumer products.

Summary

• Operates as a shell company seeking a merger or similar business opportunity, with a current focus on consumer products but no specific target identified.
• No operating revenue; 2025 net loss of $154,066 versus $156,380 in 2024.
• Cash and cash equivalents of $1,077,142 as of December 31, 2025; cash used in operations of $36,644 in 2025.
• General and administrative expenses of $186,997; interest income of $44,997 in 2025.
• Derivative warrant liabilities totaled $2,980 at year-end 2025 (unchanged from 2024).
• OTC Pink quotation under PMVC (common) and PMVC.WS (warrants); securities were voluntarily delisted from NYSE effective October 21, 2022.
• Significant capital structure changes completed: trust account fully liquidated after redemptions on December 27, 2022; reverse stock split (43.792-for-1) effective March 12, 2024; Class C renamed Class A; elimination of former SPAC trust provisions.
• Super-voting structure: Class B common has 10 votes per share and exclusive right to vote on director elections; Class A holders cannot vote on director elections.
• As of March 30, 2026, 73,169 Class A shares and 26,831 Class B shares outstanding; only 1 holder of record for each class.
• Sponsor or affiliates may provide up to $1.5 million in working capital loans, convertible into private warrants at $1.00 per warrant; company may issue equity or incur debt to complete a transaction.
• Internal controls and disclosure controls deemed effective; no material cybersecurity incidents reported over the past three years.
• Company is no longer an Emerging Growth Company after December 31, 2025 and faces increased reporting/compliance requirements; remains a Smaller Reporting Company.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a cautious profile: modest cash runway and low burn are positives, but lack of a target, OTC Pink quotation, governance concentration, and potential dilution risks weigh on sentiment.

Positives

• Tight cash burn: only $36,644 net cash used in operations during 2025 with $1,077,142 cash on hand at year-end.
• Net loss modest at $154,066 for 2025, supported by $44,997 of interest income.
• No legal proceedings and no material cybersecurity incidents reported over the last three years.
• Disclosure controls and internal control over financial reporting assessed as effective as of December 31, 2025.
• Sponsor backstop flexibility: up to $1.5 million in potential working capital loans convertible into private warrants at $1.00 per warrant.
• Deferred underwriting fees from IPO previously derecognized, removing a contingent liability headwind.
• Experienced sponsor/management team with M&A, capital markets, and consumer sector backgrounds.

Negatives

• No revenues and no identified transaction; continued operating losses ($154,066 in 2025).
• OTC Pink quotation with limited and sporadic trading; aggregate market value held by non-affiliates reported as $0 as of June 30, 2025.
• Governance heavily concentrated: Class B shares have 10 votes per share and exclusively elect directors; Class A cannot vote on directors.
• Warrants are deeply out-of-the-money post reverse split: exercise price approximately $503.61 per share.
• Significant related-party dependency: $10,000/month administrative services fee; related-party payables of $632,000 at year-end 2025.
• Single holder of record for each class of common and warrants as of March 30, 2026, underscoring extreme ownership concentration and liquidity risk.
• Loss of Emerging Growth Company status after December 31, 2025 increases compliance costs.
• Past NYSE delisting (effective October 21, 2022) constrains liquidity and may impede capital formation.

Risks

• Inability to identify and consummate a suitable business opportunity; resources and competition from other acquirers may hinder deal execution.
• Conflicts of interest: officers and directors have obligations to other entities and may face conflicts in presenting and prioritizing opportunities.
• Potential reliance on a single acquired business with limited diversification, heightening exposure to sector or product risks.
• Limited resources may make financial condition unattractive to targets; may need additional financing to complete a transaction.
• Public shareholders (Class A) cannot vote on director elections; Class B super-voting (10 votes/share) gives outsized influence to founders.
• OTC Pink quotation entails reduced liquidity, wider spreads, and price volatility; securities may be considered penny stock with additional broker requirements.
• Warrants classified as liabilities; fair value changes may create non-cash P&L volatility and warrants may expire worthless.
• Risk of being deemed an investment company if asset mix and activities trigger Investment Company Act thresholds.
• Cybersecurity risks from reliance on affiliated service provider infrastructure; a breach could disrupt operations and incur costs.
• Tax uncertainties, including potential 1% federal excise tax on redemptions and risk of personal holding company tax.
• If a target is outside the U.S., additional cross-border risks including regulation, FX, tax, and legal system uncertainties.
• Increased reporting and compliance costs after loss of Emerging Growth Company status may strain resources.

Future Outlook

Management plans to continue sourcing and evaluating business opportunities—primarily in consumer products but not limited by sector or geography—using cash, stock, debt, or a combination thereof. Additional financing may be required to complete a transaction, and sponsor loans (up to $1.5 million) may support working capital needs. The company believes current cash is sufficient for operating the search but not necessarily for closing a transaction.

Management Comments

• Intends to effectuate a business opportunity using cash, capital stock, debt, or a combination of these.
• Search is focused on consumer products, though not limited to any industry or geography.
• Acknowledges potential need for additional financing to consummate a transaction and potential sponsor working capital loans.
• Notes that disclosure controls and procedures and internal controls over financial reporting were effective as of year-end 2025.

Industry Context

StockSavvy.ai notes that post-2022 SPAC market conditions remain challenging, with widespread redemptions, delistings to OTC venues, and an abundance of SPAC shells competing for a smaller pool of high-quality targets. Liquidity constraints and higher compliance burdens have increased execution risk relative to SPAC booms of 2020–2021.

Comparison to Industry Standards

• Relative to typical SPAC warrants originally struck at $11.50 pre-split, PMVC’s reverse split lifted the effective exercise price to approximately $503.61 per share, rendering them far more out-of-the-money than industry norms for active post-combination entities.
• Unlike SPACs that completed de-SPACs and maintained exchange listings (e.g., DraftKings or Rocket Lab post-merger), PMVC’s OTC Pink quotation materially limits liquidity and institutional participation.
• In line with SPACs that liquidated trust accounts amid high redemptions (e.g., Pershing Square Tontine’s wind-down), PMVC’s trust was terminated in December 2022 and the vehicle now resembles a cash shell with modest burn.
• Governance concentration (Class B super-voting and director-election exclusivity) is more sponsor-friendly than many traditional small-cap peers on national exchanges, and less aligned with one-share-one-vote corporate governance best practices.

Corporate Governance

Legal Proceedings

• No legal proceedings disclosed.

Related Party Transactions

• Pays an affiliate of the Sponsor a $10,000 per month administrative services fee; related-party payables totaled $632,000 at December 31, 2025.
• Invested $1,063,828 of cash equivalents in the Gabelli U.S. Treasury Money Market Fund (affiliated) at year-end 2025.
• Sponsor purchased 204,200 shares of Class C common on February 27, 2023 for $42,000.
• Sponsor contributed 200,000 Class B shares to facilitate the 2022 extension and converted 3,000,000 Class B to Class A on October 17, 2022.

Stakeholder Impact

• Shareholders face limited liquidity due to OTC Pink quotation, with potential wide spreads and sporadic trading.
• Class A shareholders have no vote on director elections; Class B super-voting shares concentrate control with founders.
• Warrant holders face a high post-split exercise price (~$503.61/share), implying low probability of in-the-money value without a transformative transaction.
• Suppliers/service providers are primarily affiliates (e.g., administrative services), indicating related-party dependence.
• Potential future capital raises (equity, debt, or convertible loans) could dilute existing holders if a transaction is pursued.

Next Steps

• Continue to source and evaluate potential business opportunities, with a current focus on consumer products.
• Assess and potentially utilize sponsor working capital loans and other financing options to support diligence and transaction costs.
• Maintain OTC Pink quotation and meet enhanced reporting obligations after loss of Emerging Growth Company status.

Key Dates

Recommendation

With no operating business, OTC Pink liquidity constraints, concentrated governance, potential dilution from future financing, and warrants far out-of-the-money, the risk/reward skews negatively for traditional investors until a credible transaction is announced with financing clarity.

Keywords

SPAC, shell company, PMV Consumer Acquisition, OTC Pink, reverse stock split, consumer products, business combination, super-voting shares, warrants, Gabelli, sponsor loans, delisting, trust account liquidation, capital raise, smaller reporting company